Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Hematology/Oncology Clinics of North America
|
October 11, 2005
The acute chest syndrome
Cage S Johnson
Hematology/Oncology Clinics of North America
|
October 11, 2005
Arterial blood pressure and hyperviscosity in sickle cell disease
Cage S Johnson
Hemoglobin
|
March 28, 2014
Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway
Vinod Pullarkat, Zhuo Meng, Stanley M Tahara, et al.
Journal of Biomolecular Screening
|
May 1, 2009
A novel high-throughput screening assay for sickle cell disease drug discovery
Eszter Pais, John S Cambridge, Cage S Johnson, et al.
Transfusion
|
June 1, 2006
Rheologic behavior of sickle and normal red blood cell mixtures in sickle plasma: implications for transfusion therapy
Tamas Alexy, Eszter Pais, Jonathan K Armstrong, et al.
American Journal of Hematology
|
November 21, 2008
Sickle cell disease summit: from clinical and research disparity to action
Kathryn Hassell, Betty Pace, Winfred Wang, et al.
American Journal of Hematology
|
November 11, 2009
Definitions of the phenotypic manifestations of sickle cell disease
Samir K Ballas, Susan Lieff, Lennette J Benjamin, et al.
BMC Blood Disorders
|
July 27, 2005
L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells
Yutaka Niihara, Neil M Matsui, Yamin M Shen, et al.
Blood Advances
|
November 21, 2024
American Society of Hematology: building a comprehensive minority recruitment and retention professional program
Margo R Rollins, Rahma M Warsame, Melody Smith, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Hematology/Oncology Clinics of North America
|
October 11, 2005
The acute chest syndrome
Cage S Johnson
Hematology/Oncology Clinics of North America
|
October 11, 2005
Arterial blood pressure and hyperviscosity in sickle cell disease
Cage S Johnson
Hemoglobin
|
March 28, 2014
Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway
Vinod Pullarkat, Zhuo Meng, Stanley M Tahara, et al.
Journal of Biomolecular Screening
|
May 1, 2009
A novel high-throughput screening assay for sickle cell disease drug discovery
Eszter Pais, John S Cambridge, Cage S Johnson, et al.
Transfusion
|
June 1, 2006
Rheologic behavior of sickle and normal red blood cell mixtures in sickle plasma: implications for transfusion therapy
Tamas Alexy, Eszter Pais, Jonathan K Armstrong, et al.
American Journal of Hematology
|
November 21, 2008
Sickle cell disease summit: from clinical and research disparity to action
Kathryn Hassell, Betty Pace, Winfred Wang, et al.
American Journal of Hematology
|
November 11, 2009
Definitions of the phenotypic manifestations of sickle cell disease
Samir K Ballas, Susan Lieff, Lennette J Benjamin, et al.
BMC Blood Disorders
|
July 27, 2005
L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells
Yutaka Niihara, Neil M Matsui, Yamin M Shen, et al.
Blood Advances
|
November 21, 2024
American Society of Hematology: building a comprehensive minority recruitment and retention professional program
Margo R Rollins, Rahma M Warsame, Melody Smith, et al.
Page
of 1